Sabra Healthcare Reit Stock Working Capital
| SBRA Stock | USD 13.94 0.29 2.12% |
Sabra Healthcare REIT fundamentals help investors to digest information that contributes to Sabra Healthcare's financial success or failures. It also enables traders to predict the movement of Sabra Stock. The fundamental analysis module provides a way to measure Sabra Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sabra Healthcare stock.
| Last Reported | Projected for Next Year | ||
| Net Working Capital | 311.9 M | 251.6 M | |
| Change In Working Capital | -2.7 M | -2.9 M | |
| Working Capital | 0.00 | 0.00 |
Sabra | Working Capital |
Sabra Healthcare REIT Company Working Capital Analysis
Sabra Healthcare's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Sabra Healthcare Working Capital | 311.89 M |
Most of Sabra Healthcare's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sabra Healthcare REIT is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Sabra Working Capital Driver Correlations
Understanding the fundamental principles of building solid financial models for Sabra Healthcare is extremely important. It helps to project a fair market value of Sabra Stock properly, considering its historical fundamentals such as Working Capital. Since Sabra Healthcare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sabra Healthcare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sabra Healthcare's interrelated accounts and indicators.
Click cells to compare fundamentals
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
Sabra Additional Paid In Capital
Additional Paid In Capital |
|
Based on the company's disclosures, Sabra Healthcare REIT has a Working Capital of 311.89 M. This is 299.0% lower than that of the Diversified REITs sector and significantly higher than that of the Real Estate industry. The working capital for all United States stocks is 78.9% higher than that of the company.
Sabra Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sabra Healthcare's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sabra Healthcare could also be used in its relative valuation, which is a method of valuing Sabra Healthcare by comparing valuation metrics of similar companies.Sabra Healthcare is currently under evaluation in working capital category among related companies.
Sabra Healthcare Current Valuation Drivers
We derive many important indicators used in calculating different scores of Sabra Healthcare from analyzing Sabra Healthcare's financial statements. These drivers represent accounts that assess Sabra Healthcare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Sabra Healthcare's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 4.0B | 3.6B | 3.0B | 2.9B | 3.3B | 3.5B | |
| Enterprise Value | 6.4B | 5.9B | 5.2B | 5.5B | 5.7B | 3.2B |
Sabra Fundamentals
| Return On Equity | 0.0047 | ||||
| Return On Asset | 0.0245 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.33 % | ||||
| Current Valuation | 5.53 B | ||||
| Shares Outstanding | 231.48 M | ||||
| Shares Owned By Insiders | 1.20 % | ||||
| Shares Owned By Institutions | 94.33 % | ||||
| Number Of Shares Shorted | 11.34 M | ||||
| Price To Earning | 67.37 X | ||||
| Price To Book | 1.14 X | ||||
| Price To Sales | 4.94 X | ||||
| Revenue | 655.85 M | ||||
| Gross Profit | 372.8 M | ||||
| EBITDA | 418.15 M | ||||
| Net Income | 13.76 M | ||||
| Cash And Equivalents | 49.05 M | ||||
| Cash Per Share | 0.21 X | ||||
| Total Debt | 2.45 B | ||||
| Debt To Equity | 0.76 % | ||||
| Current Ratio | 0.78 X | ||||
| Book Value Per Share | 12.12 X | ||||
| Cash Flow From Operations | 301.12 M | ||||
| Short Ratio | 6.20 X | ||||
| Earnings Per Share | 0.06 X | ||||
| Price To Earnings To Growth | 3.15 X | ||||
| Target Price | 15.91 | ||||
| Number Of Employees | 48 | ||||
| Beta | 1.17 | ||||
| Market Capitalization | 3.23 B | ||||
| Total Asset | 5.39 B | ||||
| Retained Earnings | (1.72 B) | ||||
| Working Capital | 311.89 M | ||||
| Current Asset | 17.25 M | ||||
| Current Liabilities | 35.18 M | ||||
| Annual Yield | 0.09 % | ||||
| Five Year Return | 9.02 % | ||||
| Net Asset | 5.39 B | ||||
| Last Dividend Paid | 1.2 |
About Sabra Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sabra Healthcare REIT's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sabra Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sabra Healthcare REIT based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:Check out Sabra Healthcare Piotroski F Score and Sabra Healthcare Altman Z Score analysis. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Sabra Stock analysis
When running Sabra Healthcare's price analysis, check to measure Sabra Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabra Healthcare is operating at the current time. Most of Sabra Healthcare's value examination focuses on studying past and present price action to predict the probability of Sabra Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabra Healthcare's price. Additionally, you may evaluate how the addition of Sabra Healthcare to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is Sabra Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.286 | Dividend Share 1.2 | Earnings Share 0.06 | Revenue Per Share 2.788 | Quarterly Revenue Growth 0.933 |
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.